期刊文献+

大麻素2型受体在宫颈上皮内瘤变和宫颈癌中的表达 被引量:1

Study on expression level of cannabinoid receptor 2 in cervical intraepithelial neoplasm and cervical cancer
下载PDF
导出
摘要 目的研究大麻素受体2(CB2受体)在正常宫颈组织、宫颈上皮内瘤变(CIN)和宫颈癌中的表达,探讨其在宫颈癌的发生发展中的作用和意义。方法采用免疫组织化学方法分别检测正常宫颈组织、各级宫颈上皮内瘤变组织和宫颈癌中CB2受体的表达情况。结果 CB2受体在正常宫颈组织、宫颈上皮内瘤变组织和宫颈癌中均有表达;宫颈上皮内瘤变组织和宫颈癌中CB2受体表达水平明显高于正常组;CB2受体表达水平随组织恶性程度的增加而升高(P均<0.01)。结论 CB2受体在宫颈上皮内瘤变组织和宫颈癌中表达明显升高,且其升高水平随病变组织恶性程度的增加而增加,提示CB2受体可能在正常宫颈组织向宫颈上皮内瘤变和宫颈癌的逐级演变过程中起着重要作用。 Objective To study the expression level and significance of cannabinoid receptor 2(CB2) in cervical intraepithelial neoplasm and cervical cancer.Methods The expression levels of CB2 in normal cervix tissue,cervical intraepithelial neoplasm and cervical cancer were measured by immunohistochemical technique.Results Higher expression level of CB2 was detected in cervical intraepithelial neoplasm and cervical cancer compared to that in normal cervical tissue.Furthermore,the expression level of CB2 was gradually increased from low-grade to high-grade in cervical intraepithelial neoplasm and cervical cancer(P 0.01).Conclusion High expression level of CB2 in cervical intraepithelial neoplasm and cervical cancer suggests CB2 plays an important role in development and progress from normal cervical tissue to cervical cancer.
出处 《临床和实验医学杂志》 2013年第3期208-209,211,共3页 Journal of Clinical and Experimental Medicine
关键词 宫颈癌 宫颈上皮内瘤变 大麻素受体2 Cervical cancer Cervical intraepithelial neoplasm Cannabinoid receptor 2
  • 相关文献

参考文献9

  • 1易为,王建六,魏丽惠.p16^(ink4a)与Ki-67用于人宫颈病变辅助诊断的比较[J].解剖学报,2008,39(3):440-443. 被引量:6
  • 2刘晓妮.HPV感染与宫颈癌及癌前病变的关系临床研究[J].中国社区医师(医学专业),2011,13(1):131-131. 被引量:13
  • 3St(a)nder S,Schmelz M,Metze D. Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin[J].Journal of Dermatological Science,2005,(03):177-188.
  • 4赵华,王建平,李恒进.大麻CB2受体在大鼠皮肤的表达分布[J].解放军医学杂志,2005,30(6):507-508. 被引量:5
  • 5Casanova ML,Blázquez C,Martínez-Palacio J. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors[J].Journal of Clinical Investigation,2003,(01):43-50.
  • 6Blázquez C,Carracedo A,Barrado L. Cannabinoid receptors as novel targets for the treatment of melanoma[J].Federation of America Societies for Experimental Biology Journal,2006,(14):2633-2635.
  • 7Sarfaraz S,Afaq F,Adhami VM. Cannabinoid receptor as a novel target for the treatment of prostate cancer[J].Cancer Research,2005,(05):1635-1641.
  • 8杨洁,赵梓纲,赵华,李恒进.大麻素抗肿瘤机制研究进展[J].中国煤炭工业医学杂志,2009,12(3):498-500. 被引量:2
  • 9Sánchez C,de Ceballos ML,Gomez del Pulgar T. Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor[J].Cancer Research,2001,(15):5784-5789.

二级参考文献42

  • 1邱云芬,范剑虹,张建兵.Cyclin D1、Ki-67在宫颈鳞状细胞癌中的表达及临床意义[J].肿瘤基础与临床,2006,19(5):377-378. 被引量:4
  • 2Antonio WZ. History of cannabis as a medicine: a review[J]. Rev Bras Pslqulatr,2006,28(2) :153 - 157
  • 3Martin BR,Mechoulam RJ, Razdan PK. Discovery and characterization of endogenous eannabinoids[J]. Life Sei, 1999;65 (6 - 7):573 - 595
  • 4Matsuda LA, Lolait SJ, Brownstein MJ, et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA[J]. Nature (Lond) ,1990,346:561 - 564
  • 5Munro S, Thomas KL, Abu- Shaar M. Molecular characterization of a peripheral receptor for cannabinoids[J]. Nature (Lond), 1993,365 : 61 - 65
  • 6Pertwee RG, Ross RA. Cannabinoid receptors and their ligands[J]. Prostaglandins Leukot Essent Fatty Acids,2002,66 (2-3):101- 121
  • 7Bouaboula M, Poinot Chazel C, Bourrie B, et al. Activation of mitogen - activated protein kinases by stimulation of the central eannabinoid receptor CBI[J]. Biochem J, 1995,312: 637 - 641
  • 8Bouaboula M, Poinot Chazel C, Marchand J, et al. Signaling pathway associated with stimulation of CB - R2 peripheral cannabinoid receptor. Involvement of both mitogen- activated protein kinase and induction of Krox- 24 expression[J]. Eur J Biochem,1996,237:704- 711
  • 9Rueda D,Galve- Roperh I, Haro A, et al. The CB1 cannabinoid receptor is coupled to the action of c- Jun N- terminal kinase[J]. Mol Pharmacol, 2000,58 : 814 - 820
  • 10Guzman M, Galve - Roperh I, Sanehez C. Ceramide, a new second messenger of cannabinoid action[J]. Trends Pharmacol Sci, 2001,22 :19 - 22

共引文献22

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部